RHÖN-KLINIKUM Aktiengesellschaft

RHÖN-KLINIKUM Aktiengesellschaft

RKAGY
RHÖN-KLINIKUM AktiengesellschaftUS flagOther OTC
8.16
USD
- -
- -
1.09BMarket Cap

Total Valuation

RHÖN-KLINIKUM Aktiengesellschaft carries a market capitalization of 1.09B, placing it among publicly traded companies globally. Its enterprise value stands at -48.03M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.09B
Enterprise Value-48.03M

Share Statistics

RHÖN-KLINIKUM Aktiengesellschaft currently has 66.94M shares outstanding.

Shares Outstanding66.94M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

RHÖN-KLINIKUM Aktiengesellschaft trades at a trailing price-to-earnings ratio of 22.32. The price-to-sales ratio is 0.54, and the price-to-book ratio stands at 0.36.

PE Ratio22.32
PS Ratio0.54
PB Ratio0.36
P/TBV Ratio0.41
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, RHÖN-KLINIKUM Aktiengesellschaft trades at an EV/EBITDA multiple of 18.98 and an EV/FCF ratio of 506.00. The EV/Sales ratio of 0.37 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 18.98 provides insight into valuation relative to core operating earnings.

EV / Sales0.37
EV / EBITDA18.98
EV / EBIT18.98
EV / FCF506.00

Financial Position

RHÖN-KLINIKUM Aktiengesellschaft maintains a current ratio of 2.63, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities.

Current Ratio2.63
Quick Ratio1.61
Debt / EquityN/A
Debt / EBITDAN/A
Interest Coverage13.70

Financial Efficiency

RHÖN-KLINIKUM Aktiengesellschaft posts a return on equity of 3.20 and a return on invested capital of 2.38.

Return on Equity (ROE)3.20
Return on Assets (ROA)2.28
Return on Invested Capital (ROIC)2.38
Return on Capital Employed (ROCE)3.16
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover31.48

Taxes

Over the trailing twelve months, RHÖN-KLINIKUM Aktiengesellschaft has paid 10.83M in income taxes, reflecting an effective tax rate of 19.73.

Income Tax10.83M
Effective Tax Rate19.73

Stock Price Statistics

RHÖN-KLINIKUM Aktiengesellschaft's stock has gained approximately 10.71913% over the past 52 weeks. The 50-day moving average sits at 8.16, while the 200-day moving average is 8.00.

Beta (5Y)N/A
52-Week Price Change10.71913%
50-Day Moving Average8.16
200-Day Moving Average8.00
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, RHÖN-KLINIKUM Aktiengesellschaft generated 1.73B in revenue and converted that into 42.09M in net income, yielding earnings per share of 0.34. EBITDA reached 40.30M, while operating income came in at 40.30M.

Revenue1.73B
Gross Profit483.89M
Operating Income40.30M
Pretax Income54.91M
Net Income42.09M
EBITDA40.30M
EBIT40.30M
Earnings Per Share (EPS)0.34

Balance Sheet

Total book value stands at 1.33B, with working capital of 562.01M providing operational flexibility.

Cash & Cash Equivalents556.55M
Total DebtN/A
Net Debt-133.08M
Equity (Book Value)1.33B
Book Value Per Share19.86
Working Capital562.01M

Margins

RHÖN-KLINIKUM Aktiengesellschaft operates with a gross margin of 27.89, reflecting its pricing power and cost economics. The operating margin of 2.32 and net profit margin of 2.43 provide insight into operational efficiency.

Gross Margin27.89
Operating Margin2.32
Pretax Margin3.17
Profit Margin2.43
EBITDA Margin2.32

Scores

RHÖN-KLINIKUM Aktiengesellschaft posts an Altman Z-Score of 2.15, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.15